Drug companies see no business value in raw material production – The Economic Times

At a time when the government is working on a policy to incentivise local manufacturing of raw materials or bulk drugs for producing medicines, the domestic industry does not see business sense in attaining self sufficiency in most raw materials. Several drug makers and trade body representatives want the government to focus on attaining self-sufficiency in producing key raw materials which go into making just about 15 essential medicines including painkillers and antibiotics to reduce dependence on China.

Read more – The Economic Times